Teachers Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Teachers Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.19M	Hold	319,507	–	–	﹤0.01%	2215
2018 Q4	$927K	Buy	319,507 +25,863	+9%	+$71.1K	﹤0.01%	2230
2018 Q3	$772K	Sell	293,644 -3,324	-1%	-$8.16K	﹤0.01%	2442
2018 Q2	$695K	Hold	296,968	–	–	﹤0.01%	2512
2018 Q1	$873K	Hold	296,968	–	–	﹤0.01%	2278
2017 Q4	$814K	Hold	296,968	–	–	﹤0.01%	2342
2017 Q3	$1.01M	Sell	296,968 -5,377	-2%	-$15K	﹤0.01%	2231
2017 Q2	$747K	Sell	302,345 -9,194	-3%	-$21.1K	﹤0.01%	2398
2017 Q1	$707K	Buy	311,539 +11,793	+4%	+$26.1K	﹤0.01%	2351
2016 Q4	$635K	Buy	299,746 +43,922	+17%	+$123K	﹤0.01%	2424
2016 Q3	$857K	Hold	255,824	–	–	﹤0.01%	2168
2016 Q2	$803K	Buy	255,824 +9,585	+4%	+$32K	﹤0.01%	2150
2016 Q1	$820K	Hold	246,239	–	–	﹤0.01%	2075
2015 Q4	$872K	Hold	246,239	–	–	﹤0.01%	2081
2015 Q3	$1.24M	Hold	246,239	–	–	﹤0.01%	1862
2015 Q2	$1.58M	Buy	246,239 +3,056	+1%	+$20.5K	﹤0.01%	1847
2015 Q1	$1.71M	Buy	243,183 +19,756	+9%	+$143K	﹤0.01%	1736
2014 Q4	$1.72M	Sell	223,427 -3,651	-2%	-$28.9K	﹤0.01%	1725
2014 Q3	$1.7M	Sell	227,078 -350,751	-61%	-$3.26M	﹤0.01%	1720
2014 Q2	$5.59M	Sell	577,829 -199,093	-26%	-$1.77M	0.01%	1095
2014 Q1	$6.46M	Buy	776,922 +22,511	+3%	+$193K	0.01%	994
2013 Q4	$6.37M	Buy	754,411 +519,360	+221%	+$4.38M	0.01%	1001
2013 Q3	$1.87M	Buy	235,051 +6,657	+3%	+$53.5K	﹤0.01%	1535
2013 Q2	$1.76M	Buy	+228,394	New	+$1.78M	﹤0.01%	1495

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Teachers Advisors's PDLI Position: Q1 2019 in Review

Teachers Advisors held its PDL BioPharma, Inc. (PDLI) position steady in Q1 2019 at 319,507 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

Teachers Advisors first reported a position in PDLI in Q2 2013 and has held it in 24 quarters since. The position peaked at $6.46M in Q1 2014. 157 funds tracked by Wall St. Rank hold PDLI as of Q1 2019.

Teachers Advisors held 319,507 shares of PDL BioPharma, Inc. worth $1.19M as of Q1 2019.
Teachers Advisors left its PDL BioPharma, Inc. share count unchanged in Q1 2019.
PDL BioPharma, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2215 holding.
Teachers Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 24 quarters since.
Teachers Advisors's PDL BioPharma, Inc. position peaked at $6.46M in Q1 2014.
157 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.